Zhong Yuan Bio-Technology Holdings Limited (ZHYBF)
Zhong Yuan Bio-Technology Holdings Limited operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Hong Kong, HK. The stock last traded at $2.02, up 0.00% on the session, giving a market capitalisation of $35.8M. On trailing twelve-month figures it carries a trailing P/E of 118.82, a net margin of 13.3%. Its beta of 4.00 implies it has historically moved more than the broad market.
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization. It also develops early detection kits for brain diseases and new drugs for neurological diseases; and technical supporting services. It sells its products under the Muzhiyuan-Neuro Enhancer brand. Zhong Yuan Bio-Technology Holdings Limited Limited is based in Wanchai, Hong Kong.
Zhong Yuan Bio-Technology Holdings Limited is most often compared with the following Healthcare names: